Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10527617rdf:typepubmed:Citationlld:pubmed
pubmed-article:10527617lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:10527617lifeskim:mentionsumls-concept:C0302600lld:lifeskim
pubmed-article:10527617lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10527617lifeskim:mentionsumls-concept:C0769865lld:lifeskim
pubmed-article:10527617pubmed:issue2lld:pubmed
pubmed-article:10527617pubmed:dateCreated1999-12-7lld:pubmed
pubmed-article:10527617pubmed:abstractTextAngiogenesis involves proliferation of capillary endothelial cells and formation of lumen-containing tube-like structures. A recently established murine brain capillary endothelial cell line, IBE, can either proliferate or form tube-like structures (i.e., differentiate) in response to fibroblast growth factor-2 (FGF-2), dependent on the culture conditions. The 4N1K peptide (KRFYVVMWKK), which is derived from the C-terminal cell-binding domain of thrombospondin-1 (TSP-1), inhibited tube formation, but not proliferation of IBE cells. Polyclonal antibodies against 4N1K blocked TSP-1-induced inhibition of tube formation by IBE cells. 4N1K inhibited tyrosine phosphorylation of focal adhesion kinase and FGF-2-stimulated tyrosine phosphorylation of phospholipase C-gamma in tube-forming, but not proliferating, IBE cells. The peptide also inhibited FGF-2-induced neovascularization in mouse cornea. Our results indicate that TSP-1 may exert its inhibitory effects on angiogenesis via the C-terminal cell-binding domain containing the 4N1K sequence by inhibiting tube formation by endothelial cells.lld:pubmed
pubmed-article:10527617pubmed:languageenglld:pubmed
pubmed-article:10527617pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10527617pubmed:citationSubsetIMlld:pubmed
pubmed-article:10527617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10527617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10527617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10527617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10527617pubmed:statusMEDLINElld:pubmed
pubmed-article:10527617pubmed:monthNovlld:pubmed
pubmed-article:10527617pubmed:issn0014-4827lld:pubmed
pubmed-article:10527617pubmed:authorpubmed-author:SaitoYYlld:pubmed
pubmed-article:10527617pubmed:authorpubmed-author:ShonoTTlld:pubmed
pubmed-article:10527617pubmed:authorpubmed-author:KandaSSlld:pubmed
pubmed-article:10527617pubmed:authorpubmed-author:KlintPPlld:pubmed
pubmed-article:10527617pubmed:authorpubmed-author:Tomasini-Joha...lld:pubmed
pubmed-article:10527617pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10527617pubmed:issnTypePrintlld:pubmed
pubmed-article:10527617pubmed:day1lld:pubmed
pubmed-article:10527617pubmed:volume252lld:pubmed
pubmed-article:10527617pubmed:ownerNLMlld:pubmed
pubmed-article:10527617pubmed:authorsCompleteYlld:pubmed
pubmed-article:10527617pubmed:pagination262-72lld:pubmed
pubmed-article:10527617pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:meshHeadingpubmed-meshheading:10527617...lld:pubmed
pubmed-article:10527617pubmed:year1999lld:pubmed
pubmed-article:10527617pubmed:articleTitleRole of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis.lld:pubmed
pubmed-article:10527617pubmed:affiliationDepartment of Urology, Nagasaki University School of Medicine, Nagasaki, Japan.lld:pubmed
pubmed-article:10527617pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10527617lld:pubmed